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Interactions between DNA and ligands are important in the rational design of drugs and
in research into DNA function. In particular, the interaction of DMZ with DNA structures named
“G-quadruplexes” was considered. G-quadruplexes are structures present in telomeres and
several oncogenes.
The main purpose of this project was to provide a computational tool to study DNAligand interactions using a variety of molecular modeling techniques that include molecular
docking, molecular dynamics simulations (MD) and MM/PBSA (Molecular Mechanics/Poisson
Boltzmann Surface Area). We investigated the binding modes and binding affinities of DMZ
with c-MYC G-quadruplexes (G4s). We found that the conformation and structural design of the
quadruplex can dramatically influence the binding profiles of the ligand. The binding free
energies for each site were estimated by the MM/PBSA method. The binding of small molecules
to DNA can result in the disruption of oncogene transcription, making it an effective anticancer
strategy.
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CHAPTER I
INTRODUCTION
1.1

Background
Cancer is a major public health issue in the world and is the second leading cause of

mortality in the United States. In 2019, there will be an estimated 1,762,450 new cancer cases
diagnosed and 606,880 cancer deaths in the United States.1 DNA damage is known to increase
the propensity for cancer. Proposed mechanisms for cancer development include oxidation,2
carcinogen exposure,3 and ultraviolet-induced strand breakage.4 Therefore, DNA serves as an
attractive anticancer target for therapeutic intervention. Zhou et al. revealed that Berenil
(diminazene aceturate or DMZ), which has been shown to bind to the minor groove of AT-rich DNA
with a micromolar dissociation constant, binds to G-quadruplexes with a nanomolar dissociation
constant, i.e. with a three orders of magnitude stronger affinity for G-quadruplexes than for AT-rich
duplexes.5 DMZ is used to treat animal trypanosomiasis and hence its toxicological profile is already
known. Thus, the DMZ scaffold is a good starting point to develop potent G-quadruplex ligands.
1.2

DNA
Deoxyribonucleic acid (DNA) is a complex molecule that contains all the genetic

information necessary to construct and maintain an organism. DNA is a linear polymer that is
comprised of a sequence of nucleotides, with each monomer containing a phosphate group, a
cyclic furanoside sugar (deoxyribose) and a nitrogenous base. The sugar is phosphorylated at the
5′ position, and a purine or pyrimidine base is attached to deoxyribose at the 1′ carbon. The most
1

common structure of DNA is the double helix proposed by Watson and Crick in 1953.6 This
duplex structure is comprised of two strands in a double helix formation. The two DNA strands
are oriented antiparallel to each other. The DNA strands are read from the 5′ to the 3′ end, where
the 5′ end terminates in a phosphate group and the 3′ end terminates in a sugar molecule. The
bases are shown in Figure 1.1.

Figure 1.1

The structure of the four nitrogenous bases.7

According to Chargaff’s rules, the two strands will engage in hydrogen bonds matching the
purine bases adenine (A) and guanine (G) with pyrimidine bases thymine (T) and cytosine (C),
respectively. The A-T combination possesses two hydrogen bonds, while the G-C interaction is
of three hydrogen bonds, as depicted in Figure 1.2.

2

Figure 1.2

Crystal structure of a dodecanucleotide showing DNA base pairs in doublestranded DNA. Adapted from Brown et al.8

The three-dimensional structure of the dodecanucleotide d(CGCGAATTCGCG). Hydrogen
bonds are shown in black with their respective distances. Guanine (top left) hydrogen bound to
cysteine (top right).8

1.3

G-quadruplex DNA
G-quadruplexes (G4) are found at specific guanine-rich regions of genes and telomeres.

Recent attention has been given to these structures because of their potential to serve as a
therapeutic target.9 Guanine has both hydrogen bond donors and acceptors, which allow four
guanines bases from a common DNA strand to align in a pseudo-plane through Hoogsteen
hydrogen bonds, resulting in a (G-G-G-G) tetrad. In a tetrad, eight hydrogen bonds stabilize the
quartet. Central cations and π orbital interactions between stacked aromatic bases help hold the
tetrad together. All G4 structures have three distinct structural features: the quadruplex stem,
formed from a set of stacked tetrads, the phosphodiester backbone, which forms the grooves, and
the unpaired bases that links the quartets and forms loops. A G4 structure can be antiparallel or
parallel depending on the position of the connecting loop, as illustrated in Figure 1.3.
3

Figure 1.3

Cartoon of a G-tetrad and typical G-quadruplex motifs. Adapted from Mikek.10

G-tetrad (top) highlighted in green. Cartoon G-quadruplexes showing the several possible
conformations including (from left to right) tetramolecular parallel, tetramolecular antiparallel,
tetramolecular mixed parallel/antiparallel, and unimolecular antiparallel. Metal cations are
represented by gold spheres only in the tetramolecular parallel G4 cartoon but are present in each
G4.10

G-quadruplexes can be regarded as being highly polymorphic in nature. G4s are in the
genome, which contains between 350,000 and 700,000 distinct putative quadruplex-forming
sequences, of which the telomeric and those present in the oncogenic promoter sequences have
been extensively studied.11–13 Quadruplex formations decrease the replicative DNA at each cell
cycle, which can lead to cell apoptosis. Telomeres are ensembles of proteins and noncoding DNA
that provides protection for chromosomes’ terminal ends from unwanted events such as
degradation, and recombination. Hence, this ability to control the mitotic clock, particularly in
cancer cells, makes G4s potential therapeutic targets for cancer treatment.14,15 G-rich strands that
form G-quadruplexes are free of the complementary C-rich strand, which allows for a myriad of
folding topologies when G-quadruplexes are formed. In humans, the single-stranded 3′ telomere
ends can extend up to 200 nucleotides (7-33 hexanucleotide repeats), which allows for many
4

self-association and specific single-stranded binding to proteins. Telomerase is a reverse
transcriptase that utilizes its own RNA template to hybridize to the DNA 3′ end and form
additional d(TTAGGG) repeats that maintain the 3′ overhangs. In over 85 % of cancers,
telomerase was identified to be upregulated.16 With this discovery, research moved toward
disrupting telomerase inhibition to alter cell growth and affect telomere maintenance.17
Moreover, apart from the telomeric region, other parts of the genome can form G-quadruplexes.
Many studies have been done on the promoter regions of the c-MYC oncogenes. The human cMYC gene is responsible for regulating the expression of proteins involved in cellular growth
and proliferation, and overexpression of c-MYC has been linked to cancer.18,19 The nuclease
hypersensitive element III1 (NHE), which is found to be present at the promoter regions of cMYC, is responsible for up to 90% of transcription.20 The c-MYC process is outlined in Figure
1.4.

5

Figure 1.4

Cartoon image showing the path of c-MYC transcription silencing by Gquadruplex stabilizing compounds. Adapted from Brooks et al.21

A shows the G-quadruplex/i-motif form of the nuclear hypersensitivity element (NHE
III1), which is the silencer element. (A) to (C) via (B) illustrates the remodeling of the Gquadruplex/i-motif complex by NM23-H2, in which a stepwise unfolding of the
secondary DNA structure is proposed to take place. Binding of nucleolin (A,D) or a Gquadruplex-interactive compound (A,E) to the silencer element prevents conversion by
NM23-H2 to the transcriptionally active form of the NHE III1(C)21

The promoter region of the c-MYC oncogene was the first to be studied and is of great
interest because 1) In several human cancers, c-MYC plays an essential role; 2) the instability of
the MYC gene product makes it a good drug target; 3) Small molecules have been reported to
stabilize the c-MYC G4 structure and down-regulate gene expression.22–24

6

1.4

G-quadruplex binders
A major focus is to design small molecules with enhanced affinity and selectivity to the

DNA substrate of telomerase and c-MYC oncogenes by stabilizing the G-quadruplex formation.
Several drug-like molecules were developed to target quadruplex formation specifically in cMYC oncogenes. Small molecules have been reported to stabilize the c-MYC G4 structure and
promote the down-regulation of gene expression. Such ligands include quarfloxin,25 TmPyP4,26
quindoline,27,28 and metal complexes.29 To stabilize a G-quadruplex structure, the binder (ligand)
should possess an aromatic system, allowing for stacking interactions with the tetrad, and should
possess an overall positive charge. The positive charges on the ligand would allow for increased
water solubility and increase electrostatic interactions with the negatively charged phosphates.
G-rich sequences with the propensity to form G4s are present in the promoter regions of several
oncogenes such as c-MYC,30 KRAS,31 and BCL2.32 An example of a ligand bound to a
quadruplex structure is shown in Figure 1.5.

7

Figure 1.5

Crystal Structure of the Quadruplex DNA-Drug Complex

Adapted from Haider et al.33

Diminazene aceturate has been reported as a tight binder to G-quadruplexes.5 In this
study, attempts have been made to characterize the binding modes of DMZ with c-MYC G4s.
Recently reported thermodynamic studies of DMZ binding to G4 suggested that DMZ does bind
to G-quadruplex. However there lacks both structural and energetic understanding of the specific
binding events.34 In this work, we carried out molecular dynamics simulations (MD) simulations
together with employing the Molecular Mechanics Poisson-Boltzmann Surface Area (MMPBSA)35 approach to explore the molecular basis of the DMZ binding to c-MYC variants based
on experimental observations of DMZ binding to c-MYC G4.34

8

CHAPTER II
COMPUTATIONAL METHODS
Normally, the modeling of DNA-ligand interactions uses two methods, which are used to
predict the binding mode and to estimate the relevant binding affinity. Molecular docking locates
the favorable binding position of a ligand, while MM/PBSA determines the binding affinity. The
binding free energy is a very useful quantity as it measures how strongly the ligand can bind to
the DNA. Calculated binding affinities can reduce the necessity to measure the ligand binding
constants experimentally, which can be very time consuming and particularly expensive. As
mentioned earlier, molecular docking is used to predict the binding modes of small molecules to
G4 DNA. However, the scoring functions that are used in docking programs do not provide
accurate binding affinities. The empirical scoring function used in molecular docking is a very
simplified method for screening many compounds. The empirical scoring functions do not
include factors like solvation, entropic effects, or sampling effects. Hence, more accurate
methods are needed to validate binding sites and identify potentially active compounds.
A type of free energy calculation method that is used with molecular docking is the
Molecular Mechanics/Poisson-Boltzmann Surface Area (MM/PBSA) method. The binding
energies are calculated using a molecular mechanical force field, the entropies are calculated by
normal mode analysis or the quasi-harmonic method, and the solvation free energy calculated by
the Poisson-Boltzmann or Generalized Born implicit solvent models. The MM/PBSA approaches
have proven successful in many research areas and are hence used in this thesis. 36 In the present
9

thesis work, the host-guest interactions described above have been investigated by isothermal
calorimetry and circular dichroism spectroscopy, which provide indirect evidence of the
interaction between ligands and DNA. Unfortunately, there lacks a descriptive mechanism of the
atomic scale process of ligand binding to c-MYC G4s.
2.1

Molecular docking
Docking is a computational method that is used to predict the binding of a ligand to its

receptors.37 The binding of a small molecule to a G-quadruplex serves as an attractive strategy
for cancer treatment. Molecular docking plays an essential role in structure-based drug design
and in the research of DNA/RNA structure and function. Numerous docking programs exist, and
much research is geared towards optimizing these methods. In this thesis, we used AutoDock
4.2.38 The process of molecular docking occurs in two stages. The first stage involves the use of
sampling algorithms to predict the orientation and position of the ligand with a defined binding
site. Autodock 4.2 uses a rapid grid-based energy method in conjunction with an efficient search
algorithm for torsions. Many studies involve a blind docking, which requires a grid to be placed
around the entire molecule to allow docking to occur at many different sites on the receptor. To
evaluate the energies in an efficient way, the potentials for each atom type is precalculated in
AutoDock. Each grid point stores the affinity potentials for all the atom types of the ligand with
the DNA. In an AutoDock simulation, the interaction energy of a ligand conformation with the
DNA is calculated from the grids. The search for ligand conformations is connected to the
torsional degrees of freedom by the various search methods implemented in Autodock.38 The
most common search algorithm used is the Lamarckian genetic algorithm (LGA),39 which uses
the genetic algorithm and a local search algorithm to achieve efficient global phase space
convergence and local search optimization. The second stage elucidates the chemical interactions
10

that exist between the ligand and its receptor, and from there it estimates binding affinities.
AutoDock uses a semi-empirical scoring function to estimate the DNA-ligand binding free
energies.38 The scoring function combines classical force fields with empirical parameters and
can rank the binding poses quickly. The enthalpic contributions are calculated with a molecular
mechanics approach, and the solvation free energy and conformational entropy are calculated by
empirical approaches. The DNA and ligand molecules start in unbound conformations and form
a bound complex after docking.
2.2

Molecular dynamics
The use of MD simulations in conjunction with automated docking is the most prevalent

method to study quadruplex-ligand interactions. Molecular dynamics allows for one to
understand the dynamic nature of the ligand binding to quadruplexes. It also provides atomistic
detail to aid in interpreting experimental findings. In an MD simulation, the classical Newtonian
equation of motion is solved. The force is calculated by taking the gradient of the potential
energy (V). The potential energy is determined using an appropriate forcefield.
⃗𝑉
𝐹 = −∇

(2.1)

By combining Newton’s second law of motion and the above equation we obtain
𝑑2 𝑟

𝑑𝑉

(2.2)

− 𝑑𝑟 = 𝑚 𝑑𝑡 2

The potential energy of the system is calculated by considering the initial coordinates of the
atoms, which can be obtained from crystal structures or homology models. The initial velocities
of the atoms are assigned randomly via the Maxwell-Boltzmann distribution at a given
temperature:
𝑚

−1 𝑚𝜐2

𝑃(𝜐) = √2𝜋𝑘𝑖 𝑇 exp ( 2
𝐵
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𝑘𝐵 𝑇

)

(2.3)

where m = mass, v = velocity, kB = the Boltzmann constant, and T = temperature.
2.2.1

Force fields
In molecular dynamics, the function of the force field is to model the potential energy of

an atomic system. The force an atom feels receives contributions from covalent bonding
parameters that include bond length, bond angle, torsions, and out-of-plane distortions, and the
non-bonded terms that include van der Waals interactions, electrostatic interactions, and
hydrogen bonding.
𝑉𝑛𝑒𝑡 = 𝑉𝐵𝐿 + 𝑉𝐵𝐴 + 𝑉𝑡𝑜𝑟𝑠𝑖𝑜𝑛 + 𝑉𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑
𝑘

𝑘

𝑉𝑛𝑒𝑡 = ∑𝑏𝑜𝑛𝑑𝑠 2 (𝑙 − 𝑙𝑖 )2 + ∑𝑎𝑛𝑔𝑙𝑒𝑠 2 (𝜃 − 𝜃𝑖 )2 + ∑𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙
𝜎

12

∑𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑 4𝜖𝑖𝑗 [( 𝑖𝑗 )
𝑟𝑖𝑗

𝜎

6

− ( 𝑟 𝑖𝑗 ) ] +
𝑖𝑗

𝑉𝑛
2

(2.4)

(1 + cos(𝑛𝜔 − 𝛾)) +

𝑞𝑖 𝑞𝑗
4𝜋𝜖𝑜 𝑟𝑖𝑗

(2.5)

In equation 2.4, the first term (VBL) is computed from the square of the difference
between the bond distance and its reference value. This accounts for bond stretching. The second
term (VBA) is calculated by squaring the difference between the bond angle and its equilibrium
value, which accounts for the harmonic bond angle potential. The torsional energy (Vtorsion), with
where ω is being periodic in the angle, (Vn) is the height of the rotational boundary, n is the
periodicity, and γ is the stage factor, which decides where the torsional point goes through its
base value. The van der Waals (vdW) potential is modeled using a Lennard-Jones potential
function which incorporates repulsive (r-12) and attractive (r-6) terms. The coulombic term
calculates the electrostatic interactions between two charged species separated rij. Most force
fields, for example, AMBER,40 CHARMM,41 NAMD,42 and GROMACS43 normally contain
parameters for proteins, nucleic acids, and other biological polymers, as well as common small
12

molecules such as ATP, ADP, NADP. The force field for a ligand is usually absent; therefore,
additional forcefield parameters must be specified. Two force fields used to generate ligand
parameters are the CHARMM general force field (CGENFF)44 and the general AMBER force
field(GAFF).45
2.2.2

Energy minimization
The initial coordinates of a system, in this case, a biological system, may not be at a local

minimum. Therefore, the system must be subjected to minimization before equilibration or
sampling in molecular dynamics. The most commonly used optimization techniques include the
steepest descent,46 conjugate gradient,47 and the Newton-Raphson method.48 In this thesis, we
have employed the use of steepest descent and conjugate gradient. Steepest descent is an
efficient algorithm for most minimization processes due to its robustness. The steepest descent
method involves taking some initial coordinates represented by a vector xi. At every step of the
calculation, we obtain the gradient (gk). The step size of each iteration may be adjusted using the
Line search method. Hence, we can locate the minima on the potential energy surface (PES).
This method is very effective if the system is located far away from the minima. However, the
convergence criterion becomes slow as the system approaches a minimum. Therefore, in the
Amber software, the initial iterations (user-defined) will be performed using the steepest descent
method followed by a conjugate gradient to quickly locate the minimum. The conjugate gradient
method makes use of the gradient history to decide a better direction for the next step. The
systems move in the direction of Vk from a point Xk. The direction is calculated using the gradient
at that point and the direction of the previous point:
𝑉𝑘 = −𝑔𝑘 + 𝛾𝑘 𝑉𝑘−1
13

(2.6)

The γk is a constant. The first step in this method is like that of the steepest descent algorithm.
A line search or arbitrary step method can be used to reach the minima.
2.2.3

Integration algorithms

In the MD simulations, the physical quantities, for example, positions, speeds, increasing speed
and so forth, are approximated utilizing Taylor series of expansions as given by
1

(2.7)

𝜐(𝑡 + 𝛿𝑡) = 𝜐(𝑡) + 𝛿𝑡𝑎(𝑡) + 2 𝛿𝑡 2 𝑏(𝑡) + ⋯

1

(2.8)

𝑎(𝑡 + 𝛿𝑡) = 𝑎(𝑡) + 𝛿𝑡𝑏(𝑡) + ⋯

(2.9)

𝑟(𝑡 + 𝛿𝑡) = 𝑟(𝑡) + 𝛿𝑡𝜐(𝑡) + 2 𝛿𝑡 2 𝑎(𝑡) + ⋯

where r = position, υ = velocity, and a = acceleration. These quantities are computed utilizing
the Verlet,49 Leap Frog,50 or Velocity Verlet algorithm.51 In this investigation, we have utilized
Velocity Verlet.
2.2.4

Timestep
There is no standard principle for picking a time step for an MD simulation. The time

step δt should be chosen to not influence the general elements of a framework or system while
investigating the phase space. One of the general rules is that the time step should be around
one-tenth of the briefest time of movement of a system. The bond stretches will have the highest
frequencies. Particularly, the period for a C-H bond stretch is around 10 fs. Therefore, the most
commonly used time step in MD is 1 fs. A constraint algorithm is a method to constrain bodies
in Newton’s equation of motion. The use of constraint algorithms is often used in MD
simulations to omit some parts of the trajectory calculations. The most commonly used algorithm
is the SHAKE algorithm.52 The SHAKE algorithm has become the standard approach for doing
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molecular dynamics with fixed bond lengths. It can also be used to hold angles fixed, but this is
less common.
2.2.5

Temperature coupling
In certain MD simulations, different properties of a biological system are assessed at a

steady temperature. Therefore, a theoretical regulator is utilized to keep a consistent temperature
all through the simulation. The temperature of a framework relies upon the average kinetic
energy.
< 𝐾 >𝑁𝑉𝑇 =
2.2.6

3
2

𝑁𝑘𝐵 𝑇

(2.10)

Pressure Coupling
Likewise, with the temperature coupling, we can use a “pressure bath” or barostat to

control the pressure of the system during a simulation. There exist many algorithms such as
Berendsen,53 which scales the box vectors and coordinates of the atoms at each of the time steps
in order to maintain a constant pressure.
2.2.7

Periodic boundary conditions
Most biological experiments are conducted in the solution phase. Therefore, simulations

are required to be immersed in an explicit solvent environment with solvent molecules and
counterions added to maintain the neutrality of the system. The box, however, must obey
Periodic Boundary Conditions (PBC). By applying Periodic Boundary Conditions and using a
minimum number of particles, one can efficiently sample the phase space and calculate various
properties of the system. Under the PBC, the box will be replicated in all 3 directions. The 2D
arrangement of this replication is shown in Figure 2.1.
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Figure 2.1

Under periodic boundary conditions, when a particle drifts out of a box, then its
image will replace it in the box

As a simulation progresses, a particle that may drift out of the box. If it does, its image
will immediately replace it in the box, as illustrated in Figure 2.1. This benefits the simulation, as
it ensures that the number of particles in the simulation is kept constant.
The calculation of non-bonded interactions is the most expensive step in performing MD
simulations. Practically, it is very difficult to calculate the sum of the nonbonded interactions, as
the number of non-bonded interactions is proportional to the square of the number of particles in
16

the system. However, in most biomolecular simulations, a non-bonded cutoff is implemented to
decrease the time of the calculation. When a non-bonded cutoff is used between pairs of atoms, if
the atoms are farther apart than the cutoff distance, the interaction is set to zero. For an accurate
simulation, all the contributions to the energy of the system should be considered overall.
However, it is impractical to attempt to sum up all the nonbonded interactions in a standard MD
simulation. Hence, one must introduce spherical cutoff distances in order to dissipate long-range
electrostatic interactions outside of the specified distance without hurting the quality of the
results.
The highly charged DNA backbone, cations, and charged ligands have a profound effect
on quadruplexes. Therefore, if the long-range interactions are poorly treated, the simulation can
become unstable. A useful method to truncate the long-range electrostatics is the particle-mesh
Ewald (PME).54,55
𝑉=

1
2

𝑁
∑′|𝑛|=0 ∑𝑁
𝑖=1 ∑𝑗=1

𝑞𝑖 𝑞𝑗
4𝜋𝜀𝑜 |𝑟𝑖𝑗 +𝑛|

(2.11)

It eliminates that fundamental problem and helps produce a stable simulation. The size of this
cutoff depends upon the case, but normally in biomolecular simulations, a suitable cutoff is
usually between 8-10 Å.
2.2.8

Ensemble averages
An ensemble must also be chosen to adequately reflect the experimental conditions. An

ensemble is a collection of phase space which corresponds to a thermodynamic (macroscopic)
state of the system.56 In MD simulations of biological molecules, different points are generated
in the phase space over time in an ensemble. MD simulations can be performed in a variety of
ensembles, e.g. canonical (NVT), microcanonical (NVE), and isobaric-isothermal (NPT), where
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the number of atoms (N), pressure (P), volume (V) and temperature (T), and/or energy (E) is
kept constant. In order to determine macroscopic properties and experimental values, the
positions (r) and momenta (p) of a system must be known. Any measured value in the system is
measured as an average over a duration of time. Hence, for an N particle system, the average
value for a particular property over a period is given by the equation:56

Aavg = ∫ ∫ dpNdrNA (pN, rN)

(2.12)

where A = an observable property of the system. In order to computationally calculate the
property of a system, an average value is replaced by an ensemble average. Wherein, numerous
replicas of a system are simultaneously considered, and the property of the system can be
represented as
< 𝐴 >= ∬ 𝑑𝑝𝑁 𝑑𝑟 𝑁 𝐴(𝑝𝑁 , 𝑟 𝑁 )𝜌(𝑝𝑁 , 𝑟 𝑁 )

(2.13)

where ρ = The probability density of the system. Under the Ergodic hypothesis,56 the ensemble
average is equal to the time average according to the equation:
𝐴𝑎𝑣𝑔 =< 𝐴 >
2.3

(2.14)

Molecular mechanics Poisson/Boltzmann and Generalized Born
Solvent effects are important to consider when studying biomolecules such as DNA, as

they often exist in water. In an MD simulation water is normally included in the simulation and
is represented explicitly by various water models such as TIP3P,57 SPC,57 or SPC/E.58 While it is
useful to add in a solvent to a simulation, this also presents an increase in computational time,
and it is also very difficult to obtain free energy values from simulations in explicit solvent in
addition as the increase in the degrees of freedom from the solvent molecules can influence the
calculation. To address this shortcoming, implicit solvation can be used to represent the solvent
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effect. Essentially, the explicit water environment is replaced by a continuum which has similar
dielectric properties as water. The usefulness of implicit solvation provides more ease in
calculating the free energies as the solvent effect is taken out. It also reduces the computational
requirement because many water molecules are represented implicitly, and the sampling is
enhanced because the conformation space due to solvent viscosity is reduced.
The prediction of ligand binding free energy to a quadruplex remains a challenging
problem to this day. Although several methods exist, for this thesis, we employed the use of the
implicit solvent methods. The free energy of binding for a receptor-ligand system can be
expressed as
∆𝐺𝑏𝑖𝑛𝑑 = ∆𝐸𝑓𝑜𝑟𝑐𝑒𝑓𝑖𝑒𝑙𝑑 + ∆𝐺𝑠𝑜𝑙 − 𝑇∆𝑆

(2.15)

where ∆E is the total energy of a system in the gas phase which is calculated by a defined
forcefield
∆𝐸 = ∆𝐸𝑏𝑜𝑛𝑑𝑖𝑛𝑔 + ∆𝐸𝑛𝑜𝑛−𝑏𝑜𝑛𝑑𝑒𝑑

(2.16)

Similarly, ∆Gsol is calculated using the following relationship
∆𝐺𝑠𝑜𝑙 = ∆𝐺𝑒𝑙𝑒𝑐 + ∆𝐺𝑣𝑑𝑤 + ∆𝐺𝑐𝑎𝑣𝑖𝑡𝑦

(2.17)

The ∆Gelec is a polar contribution i.e. associations between charged solutes and polarized
solvent. The last two terms are considered as non-polar contributions. The solvent molecules
must reorganize and create a cavity when a solute is added to a pure solvent. In this way, the
entropy of the solvent declines, and the term ∆Gcavity will be positive. The ∆Gsol is the solvation
free energy. Different techniques have been proposed for ascertaining ∆Gelec. The molecular
mechanics energies joined with the Poisson– Boltzmann59 or Generalized Born60 and surface
region continuum solvation (MM/PBSA and MM/GBSA) strategies are well-known ways to
estimate the free energy of the binding of small ligands to biological macromolecules. The
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electrostatic contribution can be obtained using the Poisson-Boltzmann (PB) or Generalized
Born (GB) model.
In the 1920s, Born developed a method to calculate the free energy of solvation when a
charged particle is transferred from in vacuo to a solvent. This in turn, can be correlated
proportionally to ∆Gelec and is represented as
∆𝐺𝑒𝑙𝑒𝑐 =

−𝑞 2
2𝑎

1

(2.18)

(1 − 𝜀 )

where q = charge of the ion, a = radius of the cavity, and ε is the dielectric constant of the
medium. The ionic radius is assigned as the radius of the cavity. We used the Generalize Born
equation for calculating electrostatic interactions within the scheme of study.61 Each particle was
represented by a sphere of radius (ri) and charge (qi). The interactions between every two atoms
are calculated, and the net electrostatic interactions of the system can be written as equation 2.19.
𝛥𝐺𝑒𝑙𝑒𝑐 ≈ ∆𝐺𝑔𝑏 =

−1
2

𝑞𝑞

1

𝑖 𝑗
𝑁
(1 − 𝜖 ) ∑𝑁
𝑖=1 ∑𝑗=1 𝑓(𝑟 ,𝑎
𝑖𝑗

𝑖𝑗 )

(2.19)

The function f depends on rij and the Born radii aij and is given by equation 2.20,
𝑓(𝑟𝑖𝑗 , 𝑎𝑖𝑗 ) = √(𝑟 2 𝑖𝑗 + 𝑎2 𝑖𝑗 𝑒 −𝐷 )

(2.20)

where aij = (aiaj)1/2 and D = r2ij/(2aij)2
In this method, the spherical particle is assumed to be filled with uniform matter and a
dielectric constant ranging from 1-4. The surrounding solvent medium is usually water,
containing a dielectric constant of 80 (F/m). In the Poisson-Boltzmann strategy, the solute and
solvent are assigned dielectric constants of 1-4 and 80 separately. A summed-up Poisson
condition is characterized as
𝛻 2 𝜙(𝑟) =
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−4𝜋𝜌(𝑟)
𝜀

(2.21)

where ϕ(r) is the electrostatic potential, ρ = charge thickness, and ε = dielectric consistent of the
medium. When we have in excess of one dielectric component in a framework, the Poisson
condition should be modified. The modified Poisson equation is known as the PoissonBoltzmann equation62 and is given by equation 2.23,
𝛻[𝜀(𝑟)𝛻𝜙(𝑟)] − 𝜅 ′2 𝑠𝑖𝑛ℎ[𝜙(𝑟)] = −4𝜋𝜌(𝑟)

(2.22)

where 𝜅 ′2 can be calculated using the Debye-Hückel inverse length, and 𝜅 is given by equation
2.23,
𝜅2 =

𝜅 ′2
𝜀

8𝜋𝑁 𝑒 2 𝐼

𝐴
= 1000𝜀𝑘

𝐵𝑇

(2.23)

where e = charge of a proton, I = ionic strength of the solution, and NA = Avogadro’s number.
In an MD simulation, the electrostatic interactions utilizing this strategy are ascertained
utilizing framework focuses. Every framework point is assigned a dielectric constant. The solute
and solvent framework focuses can be recognized by evaluating the solvent available zone.
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CHAPTER III
RESULTS AND DISCUSSION
3.1

Simulation protocols
We constructed the DNA-ligand systems using the c-MYC G-quadruplex (PBD ID:

2LBY) as a template.30 The ligand molecule present in the PDB structure was removed to allow
for docking of the DMZ. From the PDB, two variants of c-MYC were modeled, the c-MYC 1-21 and c-MYC-1-6-1 based on the sequences shown in Figures 3.1 to 3.2.

1

10
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5′ -d(TAGGGAGGGTAGGGAGGGT)-3′
Figure 3.1

Structure of PDB ID: 2LBY c-MYC G-quadruplex

Structure of human parallel c-MYC G-quadruplex DNA used in this study. (A), parallel c-MYC G4 DNA (PDB ID:
2LBY) with K+ ions. 5′ and 3′ of the DNA chain are indicated by a red and blue, respectively. K + ions are indicated
by yellow balls.
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1
10
24
5′-d(TTTTTAGGGTGGGGAGGGTGGGGA)-3′
Figure 3.2

Structure of c-MYC 1-2-1 G-quadruplex

Parallel c-MYC-1-2-1 G4 DNA with K+ ions. 5′ and 3′ of the DNA chain are indicated by a red and blue,
respectively. K+ ions are indicated by yellow balls.

1
10
24
5′-d(TGGGGAGGGTTTTTAGGGTGGGGA)-3′
Figure 3.3

Structure of c-MYC 1-6-1 G-quadruplex

Parallel c-MYC-1-6-1 g-quadruplex with K+. 5′ and 3′ of the DNA chain are indicated by a red and blue,
respectively. K+ ions are indicated by yellow balls.
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Figure 3.4

2D Structure of DMZ

The models were constructed by taking the crystal structure of a G4 core from the protein
data bank and modifying the loops to match the sequence of the oligonucleotides used for the
experiments. Two potassium ions were manually added to the cavity between consecutive Gquartets of the parallel structures as the K+ ions are needed to stabilize the tetrad. A short MD
simulation was performed to acquire the starting structure for docking using Autodock 4.2.37 We
docked DMZ to the different c-MYC G4s, while AutodockTools 1.5.6 was employed to create
the AutoGrid points of the DMZ-c MYC G-quadruplexes. The grid maps were established by
centering the grid box on the entire molecule to locate all possible binding sites. The grid
consisted of 126 x 126 x 126 grid points with a 0.375 Å spacing, which allowed the ligand to
explore the whole conformational space. The Lamarckian genetic algorithm was used for
docking with a maximum number of 2.5 x 106 energy evaluations with an initial population of
500 randomly placed individuals having a mutation rate of 0.02 along with a maximum number
of 27000 generations. A crossover rate of 0.8 and 300 iterations of local search were used. All
other docking parameters were left at default values. For the ligand, 150 independent docking
runs were carried out. The output of the docking conformations was clustered based on RMSD
between the cartesian coordinates of the ligand atoms (cutoff = 2.0 Å) and was ranked based on
the scoring function. The best-docked structures were selected based on the lowest binding
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energies and preferential binding sites based on experimental work done by Mikek et al.34 The
chemical structure of the ligand used in this study is shown in Fig. 3.4. The DMZ was optimized
at the HF/6-31G* level using Spartan 14.63 Atom types and bond types were assigned using the
antechamber program of AMBER 14.64 The conformer with the lowest energy was used for the
molecular docking. The partial charges and electrostatic potential of the DMZ molecule were
obtained at the HF/6-31G* level after geometry optimization at the same level; the electrostatic
potential using the RESP (Restrained Electrostatic Potential)65,66 method determined the partial
charges. Other force field parameters were taken from the AMBER GAFF force field.45 The
DNA-ligand systems were solvated in a truncated octahedron water box with 10 Å of water
molecules between the system and the edges of the box added. Additionally, K+ ions were added
as counter ions to neutralize the system. To simulate a salt concentration of 0.15 M, we added
additional K+ and Cl- ions. A refined version of the ff144SB force field with the parmbsc0
nucleic acid parameters67 was applied to represent the DNA fragments, along with the TIP3P
model57 for the water molecules. The system was minimized by 500 steepest descent energy
minimizations and then 500 steps of conjugate gradient minimization with constraints of 50 kcal
mol-1 Å and 500 kcal mol-1 Å on the central K+ ions and the G4-DNA, respectively. The entire
system was then subjected to 3000 steps of steepest descent followed by 500 steps of conjugate
gradient minimization. The system was heated for 100 ps from 10 K to 300 K under NVT
conditions with a restraint of 5.0 kcal/mol/Å2 on the G4 DNA. Next, it was equilibrated for 900
ps at 300 K under NPT conditions. During the equilibration and sampling process, the hydrogens
were constrained using the SHAKE68 algorithm, and a constant temperature was maintained
using Langevin dynamics with a collision frequency of 1.0 ps-1 The electrostatic interactions
were handled using a Particle Mesh Ewald (PME) summation55 under periodic boundary
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conditions with a 10 Å cutoff. All the dynamics were performed with a time step of 2 fs. Under
NPT conditions, the unrestrained MD simulations were performed for 100 ns using the CUDA
version of PMEMD.69 The same MD simulation protocol was followed for the ligand-free G4
DNA. The output trajectory files were saved every 1 ps for further analysis, with the last 50 ns of
the trajectory chosen for the MM-PBSA calculation.
3.2

MM/PBSA
The binding free energies were calculated using the MM-PBSA approach. 35,70,71 The

dielectric constants were set to 1 for the solute and 80 for the surrounding solvent molecules. The
K+ radius was set to 1.33 Å.72 A total of 400 snapshots were taken from the last 50 ns using the
single trajectory approach. For each snapshot, the free energy was calculated for each species
(complex, ligand, and quadruplex) using equation 3.1,

∆Gbind = Gcomplex – GDNA - Gligand

(3.1)

where Gcomplex, GDNA and Gligand are complex, G4, and ligand free energies, respectively.
Each was calculated using

∆Gbind = ∆EMM + ∆Gsolv -T∆S

(3.2)

The enthalpy change ∆EMM in the gas phase upon ligand binding, is obtained by the sum
of the bonded terms (bond energy, angle energy, and torsional energy) and non-bonded terms
(van der Waals energy and electrostatic energy), ∆Gsolv is the solvation free energy, and -T∆S is
the entropic contribution at temperature T, which T was 300 K. The molecular mechanics free
energy was calculated from equation 3.3.

EMM = ∆Ebond + ∆Eangle + ∆Etorsion + ∆Evdw + ∆EEEL

26

(3.3)

The solvation free energy was calculated using equation 3.4 where ∆GPB was the polar
contribution to solvation obtained by solving the Poisson-Boltzmann equation for the MM-PBSA
method.

∆Gsolv = ∆GPB + ∆Gnp

(3.4)

∆Gnp is the nonpolar contributions to solvation, which is computed by equation 3.5 where γ is the
surface tension that was set to 0.0072 kcal/ (mol- Å2) and β was a constant = 0.00 kcal/(mol- Å2).

∆Gnp = γ*∆SASA + β

(3.5)

SASA is the solvent accessible surface area (Å2) that is used to derive the nonpolar free
energy (∆Gnp) as per equation 3.5 and estimated using the MOLSURF algorithm. The solvent
probe radius was set to 1.4 Å to define the electric boundary around the molecular surface. Note
that since the solute conformational entropy is not included in our analysis, the binding energies
by MMGPSA generally over-estimate the true binding free energy (i.e. the binding affinity).
However, when the solute conformational entropies in different binding poses are comparable,
the relative binding free energy can be estimated from the relative MMGBSA binding energies.73
3.3

Results and discussion
In the present study, DMZ was docked into different c-MYC G-quadruplex variants. It

was revealed that DMZ, which has shown to bind to the minor groove of AT-rich DNA with a
micromolar dissociation constant, binds to G-quadruplexes with a nanomolar dissociation
constant. Therefore it serves as an attractive scaffold for developing effective G-quadruplex
ligands.5,74 Each DMZ was docked with G4s, and docking conformations with the lowest energy
of the best cluster were taken for further analysis. To explore other possible binding modes, we
selected binding poses that included groove binding, top stacking, bottom stacking, and loop
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binding to explore the possibilities of other distinct binding modes. However, it is important to
note that the scoring function in the docking program does not provide accurate binding free
energies. Therefore, it is common to validate binding poses with a more accurate method, the
MM/PBSA method.
3.3.1

Molecular docking
Molecular docking employing Autodock 4.238 provided the most suitable poses for ligand

interactions with the c-MYC G4 DNA. For each ligand, 150 docked poses were generated, and
the maximum number of poses and energy showed that the binding site of DMZ can occur at the
loops, grooves, and both the top and the bottom of the tetrads. Consequently, 100 ns of
unrestrained MD simulations were carried out on six G4–ligand complexes for each quadruplex
with DMZ bound at different positions. To compare the ligand-induced conformational changes
in the c-MYC G4 DNA, MD simulations of 2LBY were carried out for 100 ns in the absence and
presence of the ligand.
3.3.2

Three drug binding modes were observed.
Starting from the docked conformations, 100 ns MD simulation were carried out on each

binding modes. The convergence of the simulations was confirmed through the RMSD and
binding free energies. Cluster analyses of the MD trajectories were carried out using USCF
Chimera75 and the CPPTRAJ module in AmberTools 14. All solvent and solute atoms except the
G4 channel ions were removed from each of the MD trajectories. The identification of major
binding modes was achieved via a clustering method, where similar structures are grouped into
the same cluster. There are quite a few metrics that can be used for such clustering. However, we
used an RMSD metric, which is essentially a measure of the similarity between two structures or
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binding modes. The best representative conformers from the six clusters were extracted to show
the non-covalent interactions. The confirmed binding modes for each of the G4s are shown in
Figure 3.5, 3.6, and 3.7.

Figure 3.5

Best representative structure from MD simulations (100 ns) of DMZ with c-MYC
1-6-1.

The backbone of the DNA is shown as a cartoon, the atoms are in stick representation, and the
ligands are sphere representation and colored by element with carbon being grey, nitrogen being
blue and hydrogen being white. K+ ions are shown as non-bonded purple spheres.
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Figure 3.6

Best representative structure from MD simulations (100 ns) of DMZ with c-MYC
1-2-1.

The backbone of the DNA is shown as a cartoon, the atoms are in stick representation, and the
ligands are sphere representation and colored by element with carbon being grey, nitrogen being
blue and hydrogen being white. K+ ions are shown as non-bonded purple spheres.

Figure 3.7

Best representative structure from MD simulations (100 ns) of DMZ with c-MYC
2LBY.

The backbone of the DNA is shown as a cartoon, the atoms are in stick representation, and the
ligands are sphere representation and colored by element with carbon being grey, nitrogen being
blue and hydrogen being white. K+ ions are shown as non-bonded purple spheres.
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3.3.2.2

End Stacking mode
End stacking refers to the binding of DMZ to the terminal G-quartets. This binding mode

is shown in all three of the G-quadruplexes. This binding mode is shown to be favorable for all
complexes, as illustrated in Table 3.1. For the c-MYC 1-6-1, the bottom binding mode exhibits
larger fluctuations, which suggest that DMZ binding to the bottom of the G-quadruplex is not as
favorable as the top binding mode. However, both binding modes are accessible based on the
MMPBSA calculations in which the binding energy for this mode varied from -40 to -48
kcal/mol. The same trend is observed for the c-MYC 1-2-1 where energy values varied from -33
to -40 kcal/mol. The crystal structure showed these two binding modes predominantly with
binding energy values that varied from -26 to -35 kcal/mol. The end stacking mode seems the
most favorable for the c-MYC 1-2-1 and the 2LBY based on the binding energies and structural
stability suggested from the RMSD graphs. Although there exists no crystal structure of c-MYC
binding with DMZ available, a crystal structure of c-MYC G4 with quindoline (PDB ID: 2L7V)
showed the end stacking binding mode with quindoline and a computational study of thioflavin T
(ThT).76 The quindoline and ThT has a similar shape to that DMZ, which suggests that two
DMZs can stack side by side on the terminal G-quartets, which is consistent with our
observations. The end stacking position is most favorable for the c-MYC 1-2-1 and 2LBY. For
the 2LBY, this is no surprise as it is not capped by terminal bases as the c-MYC 1-2-1 is or
possesses edgewise loops as the c-MYC 1-6-1 does. Interestingly, for the c-MYC 1-2-1, the
longer 5` tail can undergo a conformational change when DMZ is bounded by folding over the
G-tetrad in the presence of the ligand.
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3.3.2.3

Groove Binding
In the groove binding mode, DMZ inserts into the groove formed by lateral loops on the

G4, similarly to those seen with B-DNA. This binding mode was observed in the c-MYC 1-6-1
and c-MYC 1-2-1 but was not observed in the 2LBY. The binding energy for the c-MYC 1-6-1
and 1-2-1 were -34 and -36 kcal/mol respectively, which was similar between the two
complexes. However, with the 2LBY, this binding mode was observed from the docking, but the
DMZ moves from the groove and into an end-stacking binding mode during the simulation,
suggesting that DMZ binding in the groove is not as favorable binding site for the c-MYC G4
when there is no terminal bases or large enough edgewise loops.
3.3.2.4

Loop insertion
This binding mode was observed in the c-MYC 1-6-1 and 2LBY but was not a favorable

binding mode in the c-MYC 1-2-1. The c-MYC 1-2-1 docked structure of the DMZ bounded
included a DMZ docked in the loop of the c-MYC 1-2-1, but it was not favorable based on the
MMPBSA calculations and its large fluctuations. For the 2LBY, the binding energy was -33
kcal/mol. While this mode was observed in the c-MYC 1-2-1 it was not favorable based on the
MMPBSA calculation, so it was excluded. Perhaps the size of the loop in the c-MYC 1-2-1 will
not allow for loop insertion. For the c-MYC 1-6-1, this binding mode showed large fluctuations,
but its MMPBSA energy (-53 kcal/mol) was the most favorable out of all binding modes
observed in the quadruplexes, making this binding pose the most favorable of the three for the cMYC 1-6-1. This suggests that the conformers with large loops are most accessible for binding
interactions with the side chains of the ligands, and therefore, they can be harnessed for the
design of novel ligands using DMZ as a template.77
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Table 3.1

Binding free energies for each complex (kcal/mol)
c-MYC 1-6-1 G4 DNA

Ligand

Site

ΔEELE

ΔEvdw

ΔEPBSUR

ΔEPBCAL

ΔEPBSOL

ΔEPBELE

ΔEPBTOT

DMZ
Aa

Loop

-1219.5 ± 14.7

-37.9 ± 2.9

-3.6 ± 0.0

1207.2 ± 11.5

1203.5 ± 11.5

-12.3 ± 5.2

-53.3 ± 4.2

DMZ
Ab

Bottom
3’

-1117.1 ± 27.3

-33.1 ± 4.1

-3.2 ± 0.0

1104.9 ± 21.2

1101.6 ± 21.1

-12.1 ± 7.9

-48.0 ± 5.5

DMZ
Ac

Groove

-966.2 ± 151.8

-27.9 ± 6.4

-2.7 ± 0.5

961.9 ± 151.6

959.2 ± 151.0 4.3 ± 3.4

-34.4 ± 7.4

DMZ
Ad

Top 5'

-992.6 ± 21.5

-31.9 ± 2.7

-2.8 ± 0.1

986.7 ± 20.2

983.9 ± 20.1

-40.1 ± 3.4

DMZ
Ae

Loop

-856.0 ± 437.1

-25.1 ± 17.8

-2.4 ± 1.7

853.4 ± 437.6

850.9 ± 435.9 -2.6 ± 3.6

-29.7 ± 19.0

-1145.1 ± 33.8

-26.6 ± 3.5

-2.9 ± 0.1

1132.0 ± 28.5

1129.0 ± 28.4

-13.0 ± 7.9

-42.1 ± 7.0

DMZ Af Bottom
3'

-5.9 ± 3.4

c-MYC 1-2-1 G4 DNA
Ligand

Site

ΔEELE

ΔEvdw

ΔEPBSUR

ΔEPBCAL

ΔEPBSOL

ΔEPBELE

ΔEPBTOT

DMZ Ba Groove

-1022.8 ± 11.5

-27.9 ± 2.5

-2.9 ± 0.0

1017.2 ± 10.2

1014.3 ±
10.23

-5.6 ± 3.0

-36.4 ± 2.7

DMZ Bb Top 5'

-1064.9 ± 54.6

-31.5 ± 3.4

-2.7 ± 0.2

1059.8 ± 53.2

1057.0 ± 53.1 -5.1 ± 5.1

-39.4 ± 4.7

DMZ Bc Bottom
3'

-972.9 ± 15.5

-25.7 ± 2.8

-2.4 ± 0.0

966.8 ± 13.3

964.3 ± 13.31 -6.1 ± 4.4

-34.3 ± 3.8

DMZ Bd Groove

-889.6 ± 20.3

-14.5 ± 2.9

-1.8 ± 0.2

875.8 ± 21.8

874.0 ± 21.68 -13.7 ± 4.2

-30.0 ± 2.6

DMZ Be Bottom
3'

-962.4 ± 13.2

-32.6 ± 2.5

-2.6 ± 0.0

964.3 ± 13.1

961.7 ± 13.08 1.9 ± 3.0

-33.3 ± 3.4

DMZ Bf Top 5'

-1123.1 ± 13.9

-32.7 ± 2.6

-3.51 ± 0.1

1122.8 ± 14.9

1119.3 ±
14.92

-0.2 ± 5.2

-36.5 ± 4.9

c-MYC 2LBY G4 DNA
Ligand

Site

ΔEELE

ΔEvdw

ΔEPBSUR

ΔEPBCAL

ΔEPBSOL

ΔEPBELE

ΔEPBTOT

DMZ Ca Loop

-851.5 ± 14.4

-33.4 ± 2.83

-3.1 ± 0.0

854.6 ± 13.0

851.5 ± 13

3.1 ± 4.8

-33.4 ± 3.8

DMZ
Cb

-810.4 ± 72.7

-22.4 ± 3.38

-2.2 ± 0.2

805.0 ± 72.7

802.7 ± 72.4

-5.3 ± 3.0

-30.0 ± 4.0

DMZ Cc Top 5'

-801.3 ± 77.8

-32.5 ± 4.80

-2.7 ± 0.3

801.7 ± 78.3

798.9 ± 78.0

0.3 ± 4.6

-34.9 ± 5.1

DMZ
Cd

Bottom
3'

-802.0 ± 14.2

-23.6 ± 2.20

-2.4 ± 0.1

800.3 ± 13.4

797.9 ± 13.4

-1.7 ± 4.6

-27.8 ± 4.3

DMZ Ce Bottom
3'

-829.6 ± 46.7

-24.4 ± 3.05

-2.5 ± 0.1

823.2 ± 46.0

820.7 ± 45.8

-6.4 ± 3.7

-33.4 ± 3.4

DMZ Cf Top 5'

-782.7 ± 12.7

-27.1 ± 1.54

-2.2 ± 0.0

785.9 ± 13.2

783.7 ± 13.1

3.2 ± 2.4

-26.1 ± 2.1

Bottom
3’

The binding free energy components of DMZ binding to c-MYC G4s in (kcal/mol). Four sites are viable for DMZ
binding: loop binding, groove binding, and end stacking at the 5' and 3' ends, as demonstrated by the negative value
of the total binding free energy. The loop and groove binding modes showed similar binding strength to all the G4s
examined.
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3.3.3

Overall structural stability
The convergence of the MD simulations was monitored by the root mean square

deviations (RMSDs) of the structures of the complex and its components with respect to the first
frame of the simulation. The comparison of RMSD graphs for the G-quartets in comparison with
the ligand-free G-quartet showed that DMZ binding stabilizes the G4 efficiently as shown in
Figures 3.8 to 3.25. The backbone atoms converged towards the last 40-50 ns of the simulations.
The RMSD graphs show that DMZ is more flexible in the groove and loop binding modes but
more rigid in the end stacking mode when complexed with the G4s. To probe the dynamics of
the nucleotides in the G4, root-mean-square fluctuations (RMSF) were calculated as illustrated in
Figures 3.26 to 2.28 For the c-MYC 1-6-1, the RMSF graph suggests that the loops and flanking
nucleotides fluctuated less in the complex with DMZ than in the ligand-free G4. For c-MYC 1-21, the 5' end nucleotides exhibited less fluctuation in comparison to the ligated G4. For the cMYC crystal structure, there was more fluctuation in the 5' end in contrast to the 3' end which
shows little fluctuation when complexed with DMZ. From the RMSF values, we can see that the
structure fluctuations originate primarily from the loop and flanking nucleotides, while the Gtetrads are quite stable in the simulations.
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Figure 3.8

RMSD of DMZ Aa with c-MYC 1-6-1 G4.

RMSD graphs of the c-MYC 1-6-1 G4 DNA and DMZ Aa complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand, respectively.

Figure 3.9

RMSD of DMZ Ab with c-MYC 1-6-1 G4.

RMSD graphs of the c-MYC 1-6-1 G4 DNA and DMZ Ab complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.

35

Figure 3.10

RMSD of DMZ Ac with c-MYC 1-6-1 G4.

RMSD graphs of the c-MYC 1-6-1 G4 DNA and DMZ Ac complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.

Figure 3.11

RMSD of DMZ Ad with c-MYC 1-6-1 G4.

RMSD graphs of the c-MYC 1-6-1 G4 DNA and DMZ Ad complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.
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Figure 3.12

RMSD of DMZ Ae with c-MYC 1-6-1 G4.

RMSD graphs of the c-MYC 1-6-1 G4 DNA and DMZ Ae complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.

Figure 3.13

RMSD of DMZ Af with c-MYC 1-6-1 G4.

RMSD graphs of the c-MYC 1-6-1 G4 DNA and DMZ Af complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.
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Figure 3.14

RMSD of DMZ Ba with c-MYC 1-2-1 G4.

RMSD graphs of the c-MYC 1-2-1 G4 DNA and DMZ Ba complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.

Figure 3.15

RMSD of DMZ Bb with c-MYC 1-2-1 G4.

RMSD graphs of the c-MYC 1-2-1 G4 DNA and DMZ Bb complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.
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Figure 3.16

RMSD of c-MYC DMZ Bc with 1-2-1 G4

RMSD graphs of the c-MYC 1-2-1 G4 DNA and DMZ Bc complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.

Figure 3.17

RMSD of c-MYC DMZ Bd with 1-2-1 G4

RMSD graphs of the c-MYC 1-2-1 G4 DNA and DMZ Bd complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.

39

Figure 3.18

RMSD of c-MYC DMZ Be with 1-2-1 G4

RMSD graphs of the c-MYC 1-2-1 G4 DNA and DMZ Be complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.

Figure 3.19

RMSD of c-MYC DMZ Bf with 1-2-1 G4.

RMSD graphs of the c-MYC 1-2-1 G4 DNA and DMZ Bf complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.
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Figure 3.20

RMSD of DMZ Ca with c-MYC 2LBY G4.

RMSD graphs of the c-MYC 2LBY G4 DNA and DMZ Ca complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.

Figure 3.21

RMSD of c-MYC DMZ Cb with c-MYC 2LBY G4.

RMSD graphs of the c-MYC 2LBY G4 DNA and DMZ Cb complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.
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Figure 3.22

RMSD of c-MYC DMZ Cc with c-MYC 2LBY G4.

RMSD graphs of the c-MYC 2LBY G4 DNA and DMZ Cc complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.

Figure 3.23

RMSD of c-MYC DMZ Cd with c-MYC 2LBY G4.

RMSD graphs of the c-MYC 2LBY G4 DNA and DMZ Cd complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.
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Figure 3.24

RMSD of c-MYC DMZ Ce with c-MYC 2LBY G4.

RMSD graphs of the c-MYC 2LBY G4 DNA and DMZ Ce complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.

Figure 3.25

RMSD of c-MYC DMZ Cf with c-MYC 2LBY G4.

RMSD graphs of the c-MYC 2LBY G4 DNA and DMZ Cf complex during the 100 ns of MD
simulations. The black, red and green lines indicate the RMSDs for the DNA backbone, Gquartet, and ligand respectively.
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Figure 3.26

RMSF of each c-MYC 1-6-1 nucleotide in complexes and apo as a function of
time.

Figure 3.27

RMSF of each c-MYC 1-2-1 nucleotide in complexes and apo as a function of
time.
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Figure 3.28

RMSF of each c-MYC 2lBY nucleotide in complexes and apo as a function of
time.

These observations suggest that, depending on the binding mode of DMZ, it can stabilize
and cause conformational changes in loops and flanking nucleotides of the G4 structures as well
as minimize the dynamic behavior.
3.3.4

Important noncovalent interactions: hydrogen-bonding and π-π stacking
It is important to note that DNA possesses a negative charge, so ligands with positive

charges such as DMZ will bind to them but without selectivity. The stability of the G4 is defined
by the hydrogen bonding and the inherent π-π stacking. In a G4, each G-quartet is held together
by eight Hoogsten hydrogen bonds (N2-H---N7 and N1-H---O6), which are the main bonds
keeping the quartet stable. To study the effects of DMZ binding on G4s, the hydrogen bond
occupancies were calculated along all the MD trajectories. For the H-bond analysis, we only
considered H-bonds in the G-tetrad with occupation rates greater than 90% for the last 50 ns of
the simulation. The analysis indicates that the H-bonds provide stability of the apo and
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complexed G-quadruplexes. However, upon DMZ binding, hydrogen bonds appear without as
large a frequency, which is concurrent with experimental observations.5 Also, the π-π stacking
interactions contribute significantly to the stability of the complexes. G4s are stable structures in
solution, so having a ligand that can promote a conformational change in the G4 may serve as an
attractive strategy. From this study, the loops provide a suitable site for DMZ binding, especially
those loops rich in thymine bases, as they are more prone to forming hydrogen bonds with
ligands such as DMZ.78
3.3.5

Binding free energies
The binding free energies were computed by means of the MM-PBSA. The results are

listed in Table 3.1. The binding free energies ranged from -26 to -53. kcal/mol. The calculated
energies are substantially overestimated, which may be because of the highly charged species
involved in this study. Based on the results, the four sites that are viable for DMZ binding are
loop binding, groove binding, and end stacking at the 5' and 3' ends, as indicated by the negative
value of the total binding free energy. The electrostatic energies (∆EELE), which arise from the
positive charges on the amidines of the DMZ and negative charges on the phosphate groups of
the quadruplexes, are shown to be favorable for all the complexes. Also, the electrostatic energy
contribution is strong enough to compensate for the contribution from the polar solvation
(∆PBSOLV). The van der Waals energy (∆Evdw), which stems from the π-interactions of DMZ with
the G-tetrad are shown to provide a favorable contribution. A slightly favorable contribution
arose from the nonpolar contribution to the solvation energy (∆EPBSUR), but the electrostatic term
to the solvation energy (∆EPBCAL) was highly unfavorable. Of all the G4 structures examined in
this work, the largest binding free energy observed was from the loop insertion binding mode in
the large-looped c-MYC 1-6-1 structure. The DMZ ligand shows the importance of positively
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charged ligands having aromatic units for binding and stabilization. The binding entropy can be
computed through quasiharmonic analysis or normal mode analysis. However, the binding
entropy was not considered here. Our aim is this work was to identify the possible binding
modes of DMZ and key interactions that play in role in the stabilizing the DMZ-G-quadruplex
structure. It should be noted that a normal mode analysis, disregards the anharmonic
contributions, which can lead to systematic errors in calculating the vibrational entropy term,
while the quasiharmonic method may fail to converge when estimating the entropy.59
3.4

Conclusion
Motivated by recent research using the DMZ scaffold to bind to G-quadruplexes, we have

performed unbiased molecular dynamics simulations to study the binding. Based on snapshots
from the simulations, the effective binding free energy between DMZ and G-quadruplexes that
was computed by the MM-PBSA approach. It is shown in this study that DMZ, which is a potent
duplex binder, can in fact bind to G-quadruplexes with high affinity and can do so by three
possible binding modes that include end stacking, loop, and groove binding. Our results are
consistent with the experimental observations34 and indicate that ligands such as DMZ can
induce a conformational change in the loop and flanking nucleotides. The large flexibility of the
loops and flanking nucleotides can be reduced, which serves as an attractive method for drug
design. Drugs that interact with loops have recently been proposed to be the most accessible for
binding.79 Our results show that DMZ can bind to different variants of c-MYC depending on its
3-dimensional structure, but it should be noted that it is not specific towards any c-MYC.
Research into G4 loops has proposed that ligand binding to the G4s can have a significant degree
of loop conformation variability.80 Of all the G4 structures examined in this work, the largest
binding free energy observed was from the loop insertion binding mode in the large-looped c47

MYC 1-6-1 structure. This feature of loops is likely to be common to all quadruplexes with
loops, whether they contain single-nucleotide or much longer loops. From the experimental work
and theoretical studies, DMZ can serve as a great template for loop specific ligands that can be
harnessed for drug design. Also, the study underlines the use of MD simulations in combination
molecular docking and MM-PBSA free energy calculations to provide a detailed description of
the energetics at the atomistic level for DMZ binding.
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